文献速递心脑血管急症

冠状动脉旁路移植术与经皮冠状动脉介入支架置入术治疗冠心病的死亡率比较:个体患者数据的汇总分析

Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.
PubMed 文献 · Lancet · 2018-02-23
一句话结论在多支血管病变患者中,CABG较PCI降低5年全因死亡率,糖尿病和冠脉复杂程度高者获益更明显;左主干病变患者两种策略死亡率相似。

该研究对截至2017年7月19日的随机临床试验进行系统综述,纳入11项比较CABG与支架PCI的试验、共11518例多支血管或左主干病变且非急性心肌梗死患者,进行个体患者数据汇总分析。中位随访3.8年,976例死亡。5年全因死亡率PCI组11.2% vs CABG组9.2%(HR 1.20,95%CI 1.06-1.37,p=0.0038)。多支血管病变患者PCI组11.5% vs CABG组8.9%(HR 1.28,95%CI 1.09-1.49,p=0.0019),糖尿病患者差异更显著(15.5% vs 10.0%,HR 1.48,95%CI 1.19-1.84,p=0.0004),无糖尿病患者无显著差异。左主干病变患者两种策略5年死亡率相似(10.7% vs 10.5%,HR 1.07,95%CI 0.87-1.33,p=0.52)。

要点

  • 多支血管病变患者5年全因死亡率PCI组11.5% vs CABG组8.9%(HR 1.28,95%CI 1.09-1.49,p=0.0019),CABG有死亡率获益。
  • 多支血管病变合并糖尿病患者5年死亡率PCI组15.5% vs CABG组10.0%(HR 1.48,95%CI 1.19-1.84,p=0.0004)。
  • 多支血管病变无糖尿病患者5年死亡率PCI组8.7% vs CABG组8.0%(HR 1.08,95%CI 0.86-1.36,p=0.49),无显著差异。
  • 左主干病变患者5年死亡率PCI组10.7% vs CABG组10.5%(HR 1.07,95%CI 0.87-1.33,p=0.52),无论糖尿病状态和SYNTAX评分均相似。

适用人群与场景

  • 纳入标准:多支血管或左主干冠状动脉病变、非急性心肌梗死、接受支架(裸金属或药物洗脱)PCI或CABG、随访超过1年且报告全因死亡率的随机临床试验患者。
  • 排除标准:急性心肌梗死患者。
  • 共纳入11项随机试验、11518例患者,由心脏团队选定接受PCI(n=5753)或CABG(n=5765)。

诊断标准与关键阈值

  • SYNTAX评分(Synergy between PCI with Taxus and Cardiac Surgery评分)均值26.0(SD 9.5),8138例中1798例(22.1%)SYNTAX评分≥33。

研究设计与关键结果

  • 研究类型:系统综述及个体患者数据汇总分析,纳入11项随机临床试验、11518例患者,平均随访3.8年(SD 1.4),976例死亡。
  • 主要终点:5年全因死亡率PCI组11.2% vs CABG组9.2%(HR 1.20,95%CI 1.06-1.37,p=0.0038)。
  • 多支血管病变亚组:5年全因死亡率PCI组11.5% vs CABG组8.9%(HR 1.28,95%CI 1.09-1.49,p=0.0019)。
  • 多支血管病变合并糖尿病亚组:5年全因死亡率PCI组15.5% vs CABG组10.0%(HR 1.48,95%CI 1.19-1.84,p=0.0004)。
  • 多支血管病变无糖尿病亚组:5年全因死亡率PCI组8.7% vs CABG组8.0%(HR 1.08,95%CI 0.86-1.36,p=0.49),无显著差异。
  • 左主干病变亚组:5年全因死亡率PCI组10.7% vs CABG组10.5%(HR 1.07,95%CI 0.87-1.33,p=0.52),无论糖尿病状态和SYNTAX评分均无显著差异。

证据类型、等级与局限

  • 证据类型:系统综述与个体患者数据汇总分析(随机临床试验)。
  • 局限:原文未报告局限性。
  • 原文指出需要更长的随访时间来更好地定义两种血运重建策略之间的死亡率差异。

对床旁实践的改变

  • 对于多支血管病变且非急性心肌梗死的患者,心脏团队决策时CABG较PCI支架置入有死亡率获益,尤其合并糖尿病和冠脉复杂程度高(SYNTAX评分高)者。
  • 对于左主干病变且非急性心肌梗死的患者,PCI与CABG的5年全因死亡率相似,无论糖尿病状态和SYNTAX评分。
  • 原文指出需要更长的随访时间来更好地定义两种血运重建策略之间的死亡率差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Numerous randomised trials have compared coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI) for patients with coronary artery disease. However, no studies have been powered to detect a difference in mortality between the revascularisation strategies.

METHODS: We did a systematic review up to July 19, 2017, to identify randomised clinical trials comparing CABG with PCI using stents. Eligible studies included patients with multivessel or left main coronary artery disease who did not present with acute myocardial infarction, did PCI with stents (bare-metal or drug-eluting), and had more than 1 year of follow-up for all-cause mortality. In a collaborative, pooled analysis of individual patient data from the identified trials, we estimated all-cause mortality up to 5 years using Kaplan-Meier analyses and compared PCI with CABG using a random-effects Cox proportional-hazards model stratified by trial. Consistency of treatment effect was explored in subgroup analyses, with subgroups defined according to baseline clinical and anatomical characteristics.

FINDINGS: We included 11 randomised trials involving 11 518 patients selected by heart teams who were assigned to PCI (n=5753) or to CABG (n=5765). 976 patients died over a mean follow-up of 3·8 years (SD 1·4). Mean Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) score was 26·0 (SD 9·5), with 1798 (22·1%) of 8138 patients having a SYNTAX score of 33 or higher. 5 year all-cause mortality was 11·2% after PCI and 9·2% after CABG (hazard ratio [HR] 1·20, 95% CI 1·06-1·37; p=0·0038). 5 year all-cause mortality was significantly different between the interventions in patients with multivessel disease (11·5% after PCI vs 8·9% after CABG; HR 1·28, 95% CI 1·09-1·49; p=0·0019), including in those with diabetes (15·5% vs 10·0%; 1·48, 1·19-1·84; p=0·0004), but not in those without diabetes (8·7% vs 8·0%; 1·08, 0·86-1·36; p=0·49). SYNTAX score had a significant effect on the difference between the interventions in multivessel disease. 5 year all-cause mortality was similar between the interventions in patients with left main disease (10·7% after PCI vs 10·5% after CABG; 1·07, 0·87-1·33; p=0·52), regardless of diabetes status and SYNTAX score.

INTERPRETATION: CABG had a mortality benefit over PCI in patients with multivessel disease, particularly those with diabetes and higher coronary complexity. No benefit for CABG over PCI was seen in patients with left main disease. Longer follow-up is needed to better define mortality differences between the revascularisation strategies.

来源:Lancet,查看原文。版权归原作者所有。

参考来源

  1. Head SJ, Milojevic M, Daemen J, et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet. 2018. PMID: 29478841. doi:10.1016/S0140-6736(18)30423-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。